NO20003964L - Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav - Google Patents

Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav

Info

Publication number
NO20003964L
NO20003964L NO20003964A NO20003964A NO20003964L NO 20003964 L NO20003964 L NO 20003964L NO 20003964 A NO20003964 A NO 20003964A NO 20003964 A NO20003964 A NO 20003964A NO 20003964 L NO20003964 L NO 20003964L
Authority
NO
Norway
Prior art keywords
receptors
models
applications
dimensional structures
dimensional
Prior art date
Application number
NO20003964A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003964D0 (no
Inventor
P Mark Hogarth
Maree S Powell
Ian F Mckenzie
Kelly F Maxwell
Thomas P J Garett
Vidana Epa
Jonathan B Baell
Barry R Matthews
Thomas D Mccarthy
Geoffrey A Pietersz
Original Assignee
Ilexus Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilexus Pty Ltd filed Critical Ilexus Pty Ltd
Publication of NO20003964D0 publication Critical patent/NO20003964D0/no
Publication of NO20003964L publication Critical patent/NO20003964L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70535Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
NO20003964A 1998-02-06 2000-08-04 Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav NO20003964L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7397298P 1998-02-06 1998-02-06
US9999498P 1998-09-11 1998-09-11
PCT/IB1999/000367 WO1999040117A1 (en) 1998-02-06 1999-02-04 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF

Publications (2)

Publication Number Publication Date
NO20003964D0 NO20003964D0 (no) 2000-08-04
NO20003964L true NO20003964L (no) 2000-10-04

Family

ID=26755120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003964A NO20003964L (no) 1998-02-06 2000-08-04 Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav

Country Status (16)

Country Link
US (2) US6675105B2 (ja)
EP (1) EP1053255A4 (ja)
JP (1) JP2004510681A (ja)
KR (1) KR20010024899A (ja)
CN (1) CN1291198A (ja)
AP (1) AP2000001876A0 (ja)
AU (1) AU759378B2 (ja)
BR (1) BR9907964A (ja)
CA (1) CA2316860A1 (ja)
EA (1) EA200000746A1 (ja)
IL (1) IL137583A0 (ja)
NO (1) NO20003964L (ja)
NZ (1) NZ505914A (ja)
PL (1) PL342297A1 (ja)
TR (1) TR200002271T2 (ja)
WO (1) WO1999040117A1 (ja)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553809B2 (en) 1998-02-06 2009-06-30 Ilexus Pty Limited Fc receptor modulators and uses thereof
CN1189166C (zh) 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
WO2000026246A2 (en) * 1998-11-05 2000-05-11 Heska Corporation Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
EP1006183A1 (en) * 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
US7912689B1 (en) 1999-02-11 2011-03-22 Cambridgesoft Corporation Enhancing structure diagram generation through use of symmetry
US7295931B1 (en) * 1999-02-18 2007-11-13 Cambridgesoft Corporation Deriving fixed bond information
US6850876B1 (en) * 1999-05-04 2005-02-01 Smithkline Beecham Corporation Cell based binning methods and cell coverage system for molecule selection
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
US7356419B1 (en) 2000-05-05 2008-04-08 Cambridgesoft Corporation Deriving product information
US7272509B1 (en) * 2000-05-05 2007-09-18 Cambridgesoft Corporation Managing product information
GB0029871D0 (en) * 2000-07-14 2001-01-24 Medical Res Council Crystal structure (V)
IL144082A0 (en) * 2000-07-14 2002-05-23 Medical Res Council Crystal structure of antibiotics bound to the 30s ribosome and its use
EP1201681A1 (en) * 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. "Fail" molecules and uses thereof
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
ES2552281T3 (es) 2001-05-11 2015-11-26 Ludwig Institute For Cancer Research Ltd. Proteínas de unión específica y usos de las mismas
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
DE10157290A1 (de) * 2001-11-22 2003-06-05 Max Planck Gesellschaft Pharmazeutische Zusammensetzung enthaltend sFcRgamma IIb oder sFcRgamma III
US20040019432A1 (en) * 2002-04-10 2004-01-29 Sawafta Reyad I. System and method for integrated computer-aided molecular discovery
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
EP2272533A1 (en) 2003-01-13 2011-01-12 MacroGenics, Inc. Soluble FcyR fusion proteins and methods of use thereof
AU2004241060B2 (en) * 2003-05-26 2009-07-23 Biotie Therapies Corp. Crystalline VAP-1 and uses thereof
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
JP2008512083A (ja) * 2004-02-10 2008-04-24 ジ・オースティン・リサーチ・インスティテュート Fc受容体の結晶構造およびモデルならびにFc受容体モジュレーター化合物の設計および同定におけるそれらの使用
WO2006133486A1 (en) * 2005-06-14 2006-12-21 The Macfarlane Burnet Institute For Medical Research And Public Health Limited CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTOR:Fc COMPLEXES AND USES THEREOF
EP2126105A4 (en) * 2007-02-20 2010-11-03 Anaptysbio Inc SOMATIC HYPERPERMUTATION SYSTEMS
WO2011140148A1 (en) * 2010-05-03 2011-11-10 Cambridgesoft Corporation Method and apparatus for processing documents to identify chemical structures
BR112013032630B1 (pt) 2011-06-30 2022-06-14 Chugai Seiyaku Kabushiki Kaisha Polipeptídeo heterodimerizado compreendendo região fc de igg
US9977876B2 (en) 2012-02-24 2018-05-22 Perkinelmer Informatics, Inc. Systems, methods, and apparatus for drawing chemical structures using touch and gestures
US11142563B2 (en) 2012-06-14 2021-10-12 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule containing modified Fc region
SG10201709559PA (en) 2012-08-24 2017-12-28 Chugai Pharmaceutical Co Ltd Fcγriib-specific fc region variant
US9535583B2 (en) 2012-12-13 2017-01-03 Perkinelmer Informatics, Inc. Draw-ahead feature for chemical structure drawing applications
DK2940135T5 (da) 2012-12-27 2021-09-20 Chugai Pharmaceutical Co Ltd Heterodimeriseret polypeptid
US8854361B1 (en) 2013-03-13 2014-10-07 Cambridgesoft Corporation Visually augmenting a graphical rendering of a chemical structure representation or biological sequence representation with multi-dimensional information
WO2014163749A1 (en) 2013-03-13 2014-10-09 Cambridgesoft Corporation Systems and methods for gesture-based sharing of data between separate electronic devices
US11267868B2 (en) 2013-04-02 2022-03-08 Chugai Seiyaku Kabushiki Kaisha Fc region variant
US9430127B2 (en) 2013-05-08 2016-08-30 Cambridgesoft Corporation Systems and methods for providing feedback cues for touch screen interface interaction with chemical and biological structure drawing applications
US9751294B2 (en) 2013-05-09 2017-09-05 Perkinelmer Informatics, Inc. Systems and methods for translating three dimensional graphic molecular models to computer aided design format
EP3538558A4 (en) 2016-11-09 2020-07-15 North Carolina State University TREATMENT OF ALLERGIC DISEASES WITH A CHIMERAL PROTEIN
CA3055172C (en) 2017-03-03 2022-03-01 Perkinelmer Informatics, Inc. Systems and methods for searching and indexing documents comprising chemical information
CN111183150B (zh) * 2017-09-15 2024-04-02 国民大学校产学协力团 Fcγ受体突变体
KR101987279B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45.1
KR101986250B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 SH2A40
KR101987268B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45
KR101987272B1 (ko) * 2017-09-15 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28.1
KR101987292B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2B45.1
KR101986252B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28
US20230192894A1 (en) * 2018-03-23 2023-06-22 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
CN115035947B (zh) * 2022-06-10 2023-03-10 水木未来(北京)科技有限公司 蛋白质结构建模方法及装置、电子设备和存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858981A (en) * 1993-09-30 1999-01-12 University Of Pennsylvania Method of inhibiting phagocytosis
CN1189166C (zh) * 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
CA2420042A1 (en) * 2000-08-22 2003-02-18 Mikio Ogawa Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient

Also Published As

Publication number Publication date
BR9907964A (pt) 2000-10-17
CA2316860A1 (en) 1999-08-12
AP2000001876A0 (en) 2000-09-30
IL137583A0 (en) 2001-07-24
PL342297A1 (en) 2001-06-04
TR200002271T2 (tr) 2000-11-21
US20040054480A1 (en) 2004-03-18
WO1999040117A1 (en) 1999-08-12
JP2004510681A (ja) 2004-04-08
EA200000746A1 (ru) 2001-04-23
EP1053255A4 (en) 2003-01-02
KR20010024899A (ko) 2001-03-26
US6675105B2 (en) 2004-01-06
US20020107359A1 (en) 2002-08-08
EP1053255A1 (en) 2000-11-22
AU2438299A (en) 1999-08-23
AU759378B2 (en) 2003-04-10
CN1291198A (zh) 2001-04-11
NZ505914A (en) 2004-03-26
NO20003964D0 (no) 2000-08-04

Similar Documents

Publication Publication Date Title
NO20003964D0 (no) Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav
DE69531681D1 (de) Spielbaustein-Set aus flexiblem Schaumstoff
PT1270565E (pt) Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
DE60020795D1 (de) Echtzeitmodellierung des Verhaltens menschlicher Sehvermögenssysteme
FR12C0012I2 (fr) Combinaisons d'herbicides et de phytoprotecteurs
DE60219242D1 (de) Dreidimensionales Rechnermodellierungsgerät
DE59910460D1 (de) Kombinationen aus herbiziden und safenern
DE69837752D1 (de) Topologie- und bewegungsmessinstrument
DE59907567D1 (de) Kombinationen aus herbiziden und safenern
NO20005343L (no) Fastsettelse av formen og orienteringen til et borehull
NO20004752D0 (no) Flerlags plastrør og bruk av samme
DE69729694D1 (de) Anbringbarer und entfernbarer Stent aus Formgedächtnisplastik
NO20013665D0 (no) Kaliumsalt av (S)-omeprazol
NO20025758D0 (no) Anvendelse av skrueviklet rörkonstruksjon i brönnmiljöet
NO985549D0 (no) Akustisk bygge-element
KR960009147A (ko) 전자 메모리와 이의 제조 및 사용 방법
DE29509295U1 (de) Aus miteinander verklebten Mauersteinen erstelltes Bauwerk
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
DE69833043D1 (de) Konsistenzerzwingung geologischer modelle
FR2827041B1 (fr) Dispositif piezoresistif et procedes de fabrication de ce dispositif
DE29506037U1 (de) Aus zwei Scharnierhälften bestehendes Kofferscharnier
DE59500890D1 (de) Rohrschalen aus Schaumkunststoff
DE29615648U1 (de) Wandbautafel aus Einzelsteinen
DE9312416U1 (de) Bauelement aus geblähten Stoffen
KR970058499U (ko) 교량의 방호벽 신축 이음구

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application